loader
Page is loading...
Print Logo Logo
human breast cell tissue


SPEAKERS

Deborah Pollack Milgate

Deborah Pollack-Milgate

Partner
Vice-Chair of the European Practice Group
Miriam Dant

Miriam Dant

President
Dant Advocacy
Kristin Jones

Kristin Jones

President and CEO
Indiana Life Sciences Association
Stephanie Rufenbarger Lesher

Stephanie Rufenbarger Lesher

Fund Director, Vice President of Development
Catherine Peachey Fund
Brian Stemme

Brian Stemme

Chief Executive Officer
Hoosier Cancer Research Network



SPEAKERS

Deborah Pollack Milgate

Deborah Pollack-Milgate

Partner
Vice-Chair of the European Practice Group
Miriam Dant

Miriam Dant

President
Dant Advocacy
Kristin Jones

Kristin Jones

President and CEO
Indiana Life Sciences Association
Stephanie Rufenbarger Lesher

Stephanie Rufenbarger Lesher

Fund Director, Vice President of Development
Catherine Peachey Fund
Brian Stemme

Brian Stemme

Chief Executive Officer
Hoosier Cancer Research Network

Breast cancer is the most frequently diagnosed cancer among women in the U.S. and in Indiana.

In 2024, an estimated 310,720 women and 2,790 men were newly diagnosed with invasive breast cancer. Indiana is already a noted Center of Excellence for cancer research and a bill currently moving through the state legislature would like to increase funding for breast cancer research and clinical trials performed here, which could help boost Indiana’s already impressive impact.

Our panel this month includes more information on Indiana HB 1299 – a bill for Funding Breast Cancer Research, a deep dive into the 30-plus year efforts of the Catherine Peachey Fund, and the latest on clinical trials and an early-stage research consortium in this space.

There will not be a Zoom option offered for this session.

Networking and lunch begin at 11:30 a.m. and the program begins at noon.

Questions? Email Audrey Cannon or call 317-229-3014.

 

Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.